The aim of this randomised, parallel, double-blind study, in which 28 adult patients diagnosed with chronic gingivitis or early stages of chronic periodontitis were recruited, was to evaluate the efficacy of 'Gamadent' toothpaste compared to a placebo toothpaste. 'Gamadent' toothpaste has all the basic constituents of a toothpaste with the addition of a sea cucumber extract (SCE) of the species Stichopus sp.
Introduction
It has been known for at least several thousand years that marine organisms contain substances capable of exhibiting patent biological activity. Undoubtedly, we are aware that most of the currently available therapeutic agents stem either directly or indirectly from naturally occurring organic molecules derived from terrestrial plants and or animals as food for daily consumption. One of these marine living beings, particularly popular in some parts of Asia is the sea cucumber (1) .
Sea cucumbers are flexible, cylindrical-bodied creatures which move sluggishly over the ocean floor using their feeding tentacles to pick up food. These marine invertebrates are known as echinoderms, meaning they are spiny-skinned, and are close relatives of the sea urchin and sea star. For hundreds of years, the golden sea cucumber of species Stichopus sp. 1, locally known as ' properties on the gingival tissues to reduce gingival inflammation which usually manifests as gingival bleeding and gingival / periodontal pockets. A clinical trial was conducted to study the effect of this toothpaste on plaque removal and resolution of gingival inflammation in patients who had either gingivitis or early stages of periodontitis.
Materials
and Methods This was a double blind study where clinical measurements were taken longitudinally at baseline and the 4th, 8th and 12th week. Subjects for the study were selected from a population who had been seen at the Primary Care Dental Unit at the Faculty of Dentistry of University of Malaya, Kuala Lumpur.
Patients chosen met a set of inclusion and exclusion criteria. Patients with a diagnosis of chronic gingivitis or early chronic adult periodontitis (periodontal pockets 5 mm and initial alveolar bone loss) were selected . They agreed to attend for treatment and clinical measurements required for the study, and consented to the protocol of the study. Patients with medical conditions such as heart disease, respiratory disease, blood dyscrasia , liver disease and kidney disease were excluded as well as those who had had antibiotics in the last 3 months , and pregnant patients.
Twenty-eight subjects were included. (Table 1 ) and the other 14 were given a placebo toothpaste (identical toothpaste minus SCE). However 2 control subjects defaulted and were excluded from the study , leaving 12 in the control group. Standard Oral-B plus , size 35 toothbrushes were dispensed with the toothpastes . The subjects were matched closely by age , sex, ethnicity and disease status. Toothpastes were dispensed in unmarked white tubes for both test and placebo samples by one of the dental surgery assistants, who kept the records . The examiners were blind to these records.
In this study, 4 teeth from each quadrant , making a total of 16 teeth, were selected in each patient: 1 st or 2nd molars, 1 st or 2nd premolars, canines, and central or lateral incisors. An alternative tooth was used if the first choice was missing or had crowns or defective restorations . The disto-buccal, mid-buccal, mesio-lingual and mid-lingual surfaces were scored for PI and GI, while the 6 surfaces scored for PPD were disto-buccal, mid-buccal , mesiobuccal, mesio-lingual, mid-lingual and disto-lingual. Serial measurements and treatment for each patient were undertaken by the same examiner throughout the study. Scaling was done with an ultrasonic scaler for all subjects. Oral hygiene instructions including flossing and the Bass technique of tooth brushing were demonstrated to all subjects by the 3 examiners using charts, models and an Oral-B toothbrush. Subjects were instructed to avoid using mouthrinses or taking antibiotics.
The sequence of treatment is illustrated as follows:
The clinical measurements made during this clinical trial were: Results The data was subjected to statistical analysis using SPSS 9.0 and comparison of the results between the test and control subjects was done using an independent t-test. All the calculations were based on 5% significance level.
The final group of subjects assessed consisted of 26 persons, 14 in the test group and 12 in the control group. There were 14 males and 12 females, with a mean age of 39.6 ± 13.2 years (age range of 19-60 years). A total 796 surfaces in the test subjects and 624 surfaces in the control group were assessed for PI and GI. A total of 1104 surfaces in the test subjects and 930 surfaces in the control group were assessed for PPD, and 306 papillae of test subjects and 261 papillae of control subjects were studied for the PBI.
The baseline mean values for the various indices are depicted in Table 2 . With the exception of the PBI, the rest of the mean values of the indices were significantly higher in the test subjects than in the control group in spite of matching the subjects and taking into consideration the 2 control patients who dropped out. Hence in the subsequent visits, mean reductions from baseline in the various indices were compared between the test and control groups to assess the effect of the SCE-containing toothpaste.
The mean reduction in the PI as shown in Table 3 was observed in both test and control sites throughout the study period, although this was consistently and significantly greater at the test sites at the 1-, 2-and 3-month intervals from baseline (P < 0.001) in comparison to the control sites. The mean reduction in PBI in the test and control groups throughout the study period is shown in Table 4 . The reduction in bleeding on probing was significantly greater at the test sites in comparison to the control sites at the 2-and 3-month intervals (P < 0.001). At the 1-month interval the reduction was greater at test sites but this is not statistically significant (P = 0.5).
Analysed data for the mean reduction of the GI from baseline is presented in Table 5 . Throughout the study period, there was improvement in gingival inflammation in both the test and control group after conventional treatment of scaling and prophylaxis at baseline. At the 1-and 3-month intervals this improvement was statistically significantly greater in the test group as compared to the control group (P < 0.001), although the increase was not significant at the end of the 2nd month.
The mean reduction in probing pocket depth is shown in Table 6 . Probing pocket depths decreased in both the test and control groups during the period of the study. However the mean reduction was greater in the control group at the 1-month interval than the test group, although not significantly. At the 2-month and 3-month intervals the mean PPD reductions were significantly greater at the test sites (P < 0.001).
Discussion
The results of the present study demonstrated that improvement in plaque control and gingival conditions can be obtained after oral hygiene instruction and full mouth scaling in patients with gingivitis and early stages of chronic adult periodontitis. This was shown in both the test and control subjects and is consistent with numerous previous studies (14) (15) (16) .
It was observed that control of plaque or reduction in accumulation of plaque (as reflected by the mean reduction in the PI) was consistently and significantly better at the test sites throughout the study period. Whether this is a direct effect of SCE on the accumulation or adherence of plaque to the tooth surfaces is an interesting issue to investigate to rule out a coincidental finding . This effect could be verified by further research and by increasing the sample size.
Gradual reduction of the papilla bleeding scores, GI scores and probing pocket depths occurred during the subsequent months at statistically significant levels more frequently at the test sites, possibly indicating that the rate of healing was greater at sites where SCE toothpaste was used. The SCE could have improved the rate of the healing process in the test group.
As the subjects included in this study were mainly patients with early stages of periodontal disease, mainly gingivitis and early periodontitis, the mean PPD of sites initially or at baseline were low, being 1.86 at the test sites and 1.74 at the control sites. Hence the dynamic range for healing or improvement is low in this group. Better appreciation of healing could occur where initial PPD scores are higher, and a greater dynamic range or potential for healing is present. This could be investigated in future studies to verify the effect of SCE on healing of pathological pockets. No side effects were reported by the patients and no clinical pathology was observed.
In conclusion, the results of the preliminary report of this study must be interpreted within the limitations of the methodology and sample size used. A limited number of patients were used in this study. We suggest a larger sample size be used in future studies investigating this toothpaste. However the preliminary observations do indicate that plaque control seemed to improve in the group using "Gamadent" toothpaste containing SCE. In addition, this extract also appeared to increase the rate of healing during the first couple of months after initial therapy in the test group. These encouraging results could be confirmed with a larger sample size. An extension of this study to patients with more advanced disease status (moderately advanced and advanced periodontitis) could also be initiated and these clinical benefits could be further verified.
